Abstract
Purpose. The purpose of the present study was to use the human colorectal carcinoma cell line, Caco-2, as a human intestinal epithelial model for studying the effects of cyclodextrins as absorption enhancers.
Methods. Cyclodextrins of varying sizes and physico-chemical characters were investigated. The effects of the cyclodextrins were evaluated by means of staining of the cytoplasma and determination of the mitochondrial dehydrogenase activity as well as by transport enhancement of the macromolecular pore marker polyethylene glycol 4000 (PEG-4000) across the Caco-2 monolayers.
Results. The transport enhancing properties of the cyclodextrins were found to follow the lipophilicity of the core in their cyclic structure. Dimethyl-β-cyclodextrin was the most powerful in all aspects and caused an increase in the permeability of the cytoplasma membrane in a concentration dependent manner. It was possible to increase the overall transport of PEG-4000 10-fold by the use of dimethyl-β-cyclodextrin in low concentrations where the toxic effects on the monolayers were insignificant. It was further observed that the basolateral membrane was significantly more sensitive to cyclodextrins than the apical membrane.
Conclusions. Since dimethyl-β-cyclodextrin was able to produce an absorption enhancing effect on PEG-4000 in concentrations where the toxic effects on Caco-2 monolayers were low it is worth to pursue the compound as an absorption enhancer.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
J. Szejtli. Medical applications of cyclodextrins. Med. Res. Rev. 14:353–386 (1994).
Y. Watanabe, Y. Matsumoto, M. Seki, M. Takase, and M. Matsumoto. Absorption enhancement of polypeptide drugs by cyclodextrins. I. Enhanced rectal absorption of insulin from hollow-type suppositories containing insulin and cyclodextrins in rabbits. Chem. Pharm. Bull. 40:3042–3047 (1992).
Z. Shao, R. Krishnamoorthy, and A. K. Mitra. Cyclodextrins as nasal absorption promoters of insulin: Mechanistic evaluations. Pharm. Res. 9:1157–1163 (1992).
Y. Watanabe, Y. Matsumoto, K. Kawamoto, S. Sayuri, and M. Matsumoto. Enhancing effects of cyclodextrins on nasal absorption of insulin and its duration in rabbits. Chem. Pharm. Bull. 40:3100–3104 (1992).
Y. Watanabe, Y. Matsumoto, M. Yamaguchi, R. Kikuchi, K. Takayama, H. Nomura, K. Maruyama, and M. Matsumoto. Absorption of recombinant human granulocyte colony-stimulating factor (rhG-CSF) and blood leukocyte dynamics following intranasal administration in rabbits. Biol. Pharm. Bull. 16:93–95 (1993).
N. G. M. Schipper, S. G. Romeijn, J. C. Verhoef, and F. W. H. M. Merkus. Nasal insulin delivery with dimethyl-β-cyclodextrin as an absorption enhancer in rabbits: Powder more effective than liquid formulations. Pharm. Res. 10:682–686 (1993).
F. W. H. M. Merkus, N. G. M. Schipper, W. A. J. J. Hermens, S. G. Romeijn, and J. C. Verhoef. Absorption enhancers in nasal drug delivery: efficacy and safety. J. Controlled Release. 24:201–208 (1993).
Z. Shao, Y. Li, T. Chermak, and A. K. Mitra. Cyclodextrins as mucosal absorption promoters of insulin. II. Effects of b-cyclodextrin derivatives on a-chymotryptic degradation and enteral absorption of insulin in rats. Pharm. Res. 11:1174–1179 (1994).
J. Szejtli. Cyclodextrins in drug formulations: Part II. Pharm. Tech. Int. 3:16–24 (1991).
I. J. Gill, A. N. Fisher, M. Hinchcliffe, J. Whetstone, N. Farraj, R De Ponti, and L. Illum. Cyclodextrins as protective agents against enhancer damage in nasal delivery systems II. Effect on in vivo absorption of insulin and histopathology of nasal membrane. Eur. J. Pharm. Sci. 1:237–248 (1994).
F. Leroy-Lechat, D. Wouessidjewe, J. P. Andreux, F. Puisieux, and D. Duchene. Evaluation of the cytotoxicity of cyclodextrins and hydroxypropylated drivatives. Int. J. Pharm. 101:97–103 (1994).
A. Gerloczy, T. Hoshino and J. Pitha. Safety of oral cyclodextrins: Effects of hydroxypropyl cyclodextrins, cyclodextrin sulfates and cationic cyclodextrins on steroid balance in rats. J. Pharm. Sci. 83:193–196 (1994).
S. D. Raeissi and R. T. Borchardt. Cultured human colon adenoma cells (caco-2) as a model to study the mechanism by which palmitoyl-DL-carnitine enhances intestinal permeability of drugs. S.T.P. Pharma Sci. 3:56–62 (1993).
E. K. Anderberg and P. Artursson. Epithelial transport of drugs in cell culture. VIII. Effect of the pharmaceutical surfactant excipient sodium dodecyl sulfate on cell membrane and tight junctional permeability in human intestinal epithelia (caco-2) cells. J Pharm. Sci. 82:392–398 (1993).
L. Hovgaard, H. Brøndsted and H. M. Nielsen. Drug delivery studies in Caco-2 monolayers. II. Absorption enhancer effects of lysophosphatidylcholines. Int. J. Pharm. 114:141–149 (1995).
Freshney, R. J., in Alan R. Liss, (ed.), Culture of animal cells. A manual of basic technique, New York, 1987, pp. 245–256.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hovgaard, L., Brøndsted, H. Drug Delivery Studies in Caco-2 Monolayers. IV. Absorption Enhancer Effects of Cyclodextrins. Pharm Res 12, 1328–1332 (1995). https://doi.org/10.1023/A:1016225707807
Issue Date:
DOI: https://doi.org/10.1023/A:1016225707807